Baxter International scored an exit as dialysis machine developer Outset Medical floated above its range in an upsized offering.

Syncona has equipped Resolution with funding to explore a restorative liver therapy based on the research of Edinburgh's Prof Stuart Forbes.

Syncona, Jeito Capital and EcoR1 Capital have co-led the Netherlands Cancer Institute-founded Neogene Therapeutics' series A round.

Astellas and Celgene-backed immuno-oncology therapy developer Oncorus has filed to raise up to $86.3m following more than $150m in funding.

Amadeus Capital Partners has hired Edward Kliphuis, who has left his role as investment director at Merck Group subsidiary M Ventures.

Small molecule drug developer C4 has fied for a $100m initial public offering, three months after the Dana-Farber Cancer Institute spinout raised a $170m round.

Kraft Group, Roche and Novartis are in line for exits after small molecule drug developer C4 filed for a $100m offering,

The MSU cancer drug spinout has been acquired on the strength of its expertise in proteasome inhibitors and preclinical pipeline.

Exosome therapy developer Codiak Biosciences – based on research at Gothenburg and MD Anderson Cancer Center – has filed to raise up to $100m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.